Shuangqing ZHAI

Dr. Shuangqing ZHAI


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 March 2020 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MLMenglin Li
Menglin Li
MHMei Han
Mei Han
ZCZijie Chen
Zijie Chen
YTYu Tang
Yu Tang
JMJie Ma
Jie Ma
SZShuangqing ZHAI
Shuangqing ZHAI
To investigate that whether an association between marital status and the female breast cancer risk exists. The MEDLINE, EMBASE and PsycINFO databases were searched from their inception to July 2019. The Newcastle-Ottawa Scale was used to rate the methodological quality of included studies. Study data were pooled using random-effects meta-analyses to compare the breast cancer risk between unmarried, widowed, divorced or lifelong single women and married women. This study is registered with PROSPERO (number CRD42018112368). Forty-nine publications were included in the meta-analysis. Compared with married women, unmarried and lifelong single women had an elevated risk of breast cancer, and the pooled ORs of case-control studies were 1.20 (95% CI: 1.07 to 1.35) and 1.24 (95% CI: 1.05 to 1.45), respectively. In the subgroup analyses under these two comparisons, hospital-based estimates and multivariate-adjusted estimates demonstrated a strong association, while population-based estimates and age-adjusted estimates produced nonsignificant results. The pooled OR of cohort studies examining the effect of being a lifelong single woman was 1.10 (95% CI: 1.04 to 1.16). Heterogeneity was moderate to substantial across case-control studies (I2: 46% to 82%), which may be partially explained by differences in geographic regions, publication years and control types. Possible publication bias was indicated by the funnel plot and Egger’s test (P = 0.03). Marital status may correlate with the risk of developing female breast cancer. However, suboptimal selection of controls, insufficient exploration of confounding effects, inadequate ascertainment of marital status, and possible publication bias may have limited the quality of the available evidence. Overall, conclusions that marital status is an independent risk factor for breast cancer could not be drawn, and further prospective rigorous cohort studies are warranted.

23 January 2019 in BMC Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
MLMenglin Li
Menglin Li
ZCZijie Chen
Zijie Chen
ZLZhenzhu Liu
Zhenzhu Liu
NZNing Zhang
Ning Zhang
JLJintao Liu
Jintao Liu
SZShuangqing ZHAI
Shuangqing ZHAI
Patients with cancer are vulnerable to depression or other depressive conditions. The aim of this paper was to evaluate the efficacy and safety of Chinese herbal medicine (CHM) for the treatment of depression or depressive symptoms in cancer patients. CENTRAL, MEDLINE, EMBASE, PsycINFO, CNKI, VIP, SinoMed, and online clinical trial registry websites were searched for relevant RCTs until May 2017. The methodological quality of each included study was assessed with the “risk of bias” tool. Review Manager 5.3.5 was used to analyze the data. We identified 18 RCTs that included data from 1441 participants. Twelve different types of Chinese herbal preparations were investigated by these studies, and they showed a better therapeutic effect in most comparisons when measured in terms of depression rating scale scores, with SMDs (95% CI) of − 2.30 (− 3.54, − 1.05) (CHM versus no treatment), − 0.61 (− 1.03, − 0.18) (CHM versus antidepressants), and − 0.55 (− 1.07, − 0.02) (CHM plus psychological treatments versus psychological treatments), or when measured in terms of treatment response rate, with RRs (95% CI) of 1.65 (1.19, 2.29) (CHM versus no treatment), 1.15 (1.03, 1.28) (CHM versus psychological treatments), 1.32 (1.07, 1.63) (CHM plus antidepressants versus antidepressants), and 1.70 (1.02, 2.85) (CHM plus psychological treatments versus psychological treatments). Compared with antidepressants, these CHMs showed borderline superiority for improving the response rate, with an RR (95% CI) of 1.08 (0.93, 1.26). Subgroup analysis based on psychiatric diagnosis (depression versus depressive symptoms) did not modify the direction of these estimates and neither could it explain the high level of heterogeneity. Patients in the CHM group experienced fewer adverse events of cardiac toxicity (P = 0.02), functional gastrointestinal disorders (P = 0.008), sleep disturbances (P = 0.02), blurred vision (P = 0.02) and fatigue (P = 0.03) than the patients in the no treatment group or the antidepressants group. According to the investigation of the twelve herbal preparations, the CHM intervention appears to alleviate depressive symptoms in cancer patients, either alone or combined with antidepressants or psychological treatments. However, a high risk of bias and high heterogeneity made the mean estimates uncertain. Well-designed trials with comprehensive and transparent reporting are warranted in the future.

2 March 2020 in IEEE Access
Verified
Journal Article
Open access
YZYun Zhang
Yun Zhang
YLYongguo Liu
Yongguo Liu
JZJiajing Zhu
Jiajing Zhu
CYChanghong Yang
Changhong Yang
WYWen Yang
Wen Yang
SZShuangqing ZHAI
Shuangqing ZHAI
Community is an important topological characteristic of complex networks, which is significant for understanding the structural feature and organizational function of networks, and community detection has recently attracted considerable research effort. Among community detection methods, label propagation technology is widely used because of its linear time complexity. However, due to the randomness of the node order of label updating and the order of label launching in label propagation, the instability of community detection approaches based on label propagation becomes a challenge. In this paper, a new label propagation algorithm, Node Ability based Label Propagation Algorithm (NALPA), is proposed to discover communities in networks. Inspired from human society and radar transmission, we design four node abilities (propagation ability, attraction ability, launch ability and acceptance ability), label influence and a new label propagation mechanism to deal with the instability and enhance the efficiency. Experimental results on 42 synthetic and 14 real-world networks demonstrate that NALPA outperforms state-of-the-art approaches in most cases. In a case study, NALPA is applied to a drug network in Traditional Chinese Medicine (TCM) and can discover the drug communities where drugs have similar efficacy for treating Chronic GlomeruloNephritis (CGN).

6 April 2015 in Chinese Journal of Integrative Medicine
Verified
Journal Article
Closed access
PDF file
YCYi-Wen Che
Yi-Wen Che
KYKe-Yu Yao
Ke-Yu Yao
YXYu-Peng Xi
Yu-Peng Xi
ZCZi-Jie Chen
Zi-Jie Chen
YLYong-Le Li
Yong-Le Li
SZShuangqing ZHAI
Shuangqing ZHAI

14 December 2023 in Frontiers in Pharmacology
Verified
Journal Article
Open access
YLYafeng Liang
Yafeng Liang
JWJunqi Wang
Junqi Wang
TWTianyi Wang
Tianyi Wang
HLHangyu Li
Hangyu Li
CYChaohui Yin
Chaohui Yin
SZShuangqing ZHAI
Shuangqing ZHAI
Background: Selenium (Se) has been reported to have an antagonistic effect on heavy metals in animals. Nevertheless, there is a lack of epidemiological research examining whether Se can mitigate the adverse effects of cadmium (Cd) and lead (Pb) on hand grip strength (HGS) in middle-aged and elderly individuals.Methods: This study used data from the 2011–2014 National Health and Nutrition Examination Survey (NHANES). HGS measurements were conducted by trained examiners with a dynamometer. Concentrations of Se, Cd, and Pb in blood were determined via inductively coupled plasma mass spectrometry. We employed linear regression, restricted cubic splines, and quantile g-computation (qgcomp) to assess individual and combined associations between heavy metals and HGS. The study also explored the potential influence of Se on these associations.Results: In both individual metal and multi-metal models adjusted for confounders, general linear regression showed Se’s positive association with HGS, while Cd and Pb inversely related to it. At varying Se-Cd and Se-Pb concentrations, high Se relative to low Se can attenuate Cd and Pb’s HGS impact. An inverted U-shaped correlation exists between Se and both maximum and combined HGS, with Se’s benefit plateauing beyond approximately 200 μg/L. Stratified analysis by Se quartiles reveals Cd and Pb’s adverse HGS effects diminishing as Se levels increase. Qgcomp regression analysis detected Se alleviating HGS damage from combined Cd and Pb exposure. Subsequent subgroup analyses identified the sensitivity of women, the elderly, and those at risk of diabetes to HGS impairment caused by heavy metals, with moderate Se supplementation beneficial in mitigating this effect. In the population at risk for diabetes, the protective role of Se against heavy metal toxicity-induced HGS reduction is inhibited, suggesting that diabetic individuals should particularly avoid heavy metal-induced handgrip impairment.Conclusion: Blood Cd and Pb levels are negatively correlated with HGS. Se can mitigate this negative impact, but its effectiveness plateaus beyond 200 μg/L. Women, the elderly, and those at risk of diabetes are more vulnerable to HGS damage from heavy metals. While Se supplementation can help, its protective effect is limited in high diabetes risk groups.

1 January 2016 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
YLYongle Li
Yongle Li
ZCZijie Chen
Zijie Chen
NYNing Yu
Ning Yu
KYKeyu Yao
Keyu Yao
YCYiwen Che
Yiwen Che
SZShuangqing ZHAI
Shuangqing ZHAI
Background. Postpartum depression (PPD) does great harm to women following childbirth. The aim of this study was to conduct a systematic review of the literature to assess the efficacy and safety of CHM for the treatment of PPD. Methods. Published or ongoing registered trials were searched for from the inception of the various databases to December 31, 2015. Data extraction and methodology assessment were conducted independently by two researchers. RevMan 5.3 software was used to analyze the data. Results. Forty‐seven registered clinical trials (RCTs) were identified and reviewed. The results showed CHM alone or in combination with routine treatments could reduce HAMD score, EPDS score, incidence of adverse events, TESS, and SERS. CHM combined with routine treatment was more effective in increasing serum estradiol levels and reducing progesterone levels than routine treatment alone. Meanwhile, pooled data revealed that MRLQS combined with routine treatments or MRLQS plus MSHS combined with routine treatments were more effective than other therapeutic methods in TCM. MRLQS plus MSHS alone was found to be an effective alternative when compared to routine treatments. Conclusions. This review suggested that CHM was safe and effective in the treatment of PPD. However, this could not be proven conclusively. To ensure evidence‐based clinical practice, more rigorously designed trials are warranted.